Revision history of "Metabolic affliction in Sjgrens syndrome individuals a relevant problem regarding specialized medical monitoring"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 07:40, 26 April 2024‎ Farmerjacket5 (Talk | contribs)‎ . . (3,602 bytes) (+3,602)‎ . . (Created page with "RESULTS In total, 123 UC patients (95% anti-TNF, 62% vedolizumab and also 3% ustekinumab experienced) were used for a average amount of 24 weeks (interquartile range 12-2...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Metabolic_affliction_in_Sjgrens_syndrome_individuals_a_relevant_problem_regarding_specialized_medical_monitoring"